Several important steps should be taken and/or considered after the identification of an oral cavity lesion: Perform a ...

The use of antiresorptive drugs for tumor-related disorders and oral, but not injectable, corticosteroids were associated with an increased risk for osteonecrosis of the jaw among patients with ...

Oral cavity cancer, often referred to as mouth cancer, is a serious health concern that affects hundreds of people globally. With a recent rise in the number of cases reported in India ...

A brain tumor is a mass of abnormal cells that grow in the brain. Brain tumors can be benign (non-cancerous) or malignant (cancerous) and can start anywhere in the brain. Malignant tumors grow rapidly ...

Izalontamab is under clinical development by Systimmune and currently in Phase II for Oral Cavity (Mouth) Cancer. According to GlobalData, Phase II drugs for Oral Cavity (Mouth) Cancer does not have ...

Zanzalintinib fumarate is under clinical development by Exelixis and currently in Phase III for Oral Cavity (Mouth) Cancer. According to GlobalData, Phase III drugs for Oral Cavity (Mouth) Cancer does ...

Vascular tumors of the liver in adult patients include cavernous hemangioma, a common benign tumor; epithelioid hemangioendothelioma, a rare, usually low-grade malignant tumor; and angiosarcoma ...

Researchers have discovered that a low-cost blood pressure medication may effectively treat a noncancerous but invasive brain tumor. Craniopharyngioma is a rare, noncancerous brain tumor near the ...

Background: Previous studies have found an association between basal metabolic rate (BMR) and various malignant neoplasms, including bone tumors. BMR is also associated with bone mineral density, but ...

Background: Epidermal growth factor receptor (EGFR) is well known as a general prognostic biomarker for head and neck tumors, however the specific prognostic value of EGFR in oral squamous cell ...